Evidence map›Paper›PMID 34687604›Full record

ArticleMolecular cell2021

Induced intra- and intermolecular template switching as a therapeutic mechanism against RNA viruses.

Richard Janissen, Andrew Woodman, Djoshkun Shengjuler, Thomas Vallet, Kuo-Ming Lee, Louis Kuijpers, Ibrahim M Moustafa, Fiona Fitzgerald, Peng-Nien Huang, Angela L Perkins and 7 more

Abstract read
In one paragraph

Article in Molecular cell, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Recombination in Positive-Strand RNA Viruses.Frontiers in microbiology · 2022
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Richard JanissenDepartment of Bionanoscience, Kavli Institute of Nanoscience, 2629 HZ Delft, the Netherlands.
Andrew WoodmanDepartment of Biochemistry and Molecular Biology, Pennsylvania State University, State College, PA 16801, USA.
Djoshkun ShengjulerViral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France.
Thomas ValletViral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France.
Kuo-Ming LeeResearch Center for Emerging Viral Infections, College of Medicine, Chang Gung University, 33302 Taoyuan, Taiwan.
Louis KuijpersDepartment of Bionanoscience, Kavli Institute of Nanoscience, 2629 HZ Delft, the Netherlands.
Ibrahim M MoustafaDepartment of Biochemistry and Molecular Biology, Pennsylvania State University, State College, PA 16801, USA.
Fiona FitzgeraldDepartment of Biochemistry and Molecular Biology, Pennsylvania State University, State College, PA 16801, USA.
Peng-Nien HuangResearch Center for Emerging Viral Infections, College of Medicine, Chang Gung University, 33302 Taoyuan, Taiwan.
Angela L PerkinsDepartment of Chemistry, University of Minnesota, Minneapolis, MN 55455, USA.
Daniel A HarkiDepartment of Chemistry, University of Minnesota, Minneapolis, MN 55455, USA; Department of Medicinal Chemistry, University of Minnesota, Minneapolis, MN 55455, USA.
Jamie J ArnoldDepartment of Biochemistry and Molecular Biology, Pennsylvania State University, State College, PA 16801, USA.
Belén SolanoDepartment of Bionanoscience, Kavli Institute of Nanoscience, 2629 HZ Delft, the Netherlands.
Shin-Ru ShihResearch Center for Emerging Viral Infections, College of Medicine, Chang Gung University, 33302 Taoyuan, Taiwan.
Marco VignuzziViral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France.
Craig E CameronDepartment of Biochemistry and Molecular Biology, Pennsylvania State University, State College, PA 16801, USA. Electronic address: craig.cameron@med.unc.edu.
Nynke H DekkerDepartment of Bionanoscience, Kavli Institute of Nanoscience, 2629 HZ Delft, the Netherlands. Electronic address: n.h.dekker@tudelft.nl.

Funding

RNA DEPENDENT RNA POLYMERASE MECHANISMR01AI045818 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ARNOLD, JAMIE JON, CAMERON, CRAIG E. · 1999 to 2025
$7.5M
NIAID NIH HHS R01 AI045818
6 · The paper itself

Abstract

Viral RNA-dependent RNA polymerases (RdRps) are a target for broad-spectrum antiviral therapeutic agents. Recently, we demonstrated that incorporation of the T-1106 triphosphate, a pyrazine-carboxamide ribonucleotide, into nascent RNA increases pausing and backtracking by the poliovirus RdRp. Here, by monitoring enterovirus A-71 RdRp dynamics during RNA synthesis using magnetic tweezers, we identify the "backtracked" state as an intermediate used by the RdRp for copy-back RNA synthesis and homologous recombination. Cell-based assays and RNA sequencing (RNA-seq) experiments further demonstrate that the pyrazine-carboxamide ribonucleotide stimulates these processes during infection. These results suggest that pyrazine-carboxamide ribonucleotides do not induce lethal mutagenesis or chain termination but function by promoting template switching and formation of defective viral genomes. We conclude that RdRp-catalyzed intra- and intermolecular template switching can be induced by pyrazine-carboxamide ribonucleotides, defining an additional mechanistic class of antiviral ribonucleotides with potential for broad-spectrum activity.

Indexed as

Recombination, GeneticAnimalsAntiviral AgentsCatalysisCells, CulturedGenetic TechniquesGenomeGenome, ViralHomologous RecombinationHumansKineticsMiceMice, TransgenicMolecular Dynamics SimulationMutagenesisNucleotidesAntiviral AgentsNucleotidesPyrazinesRibonucleotidesRNARNA-Dependent RNA PolymeraseRNA, Viralbacktrackingcopy-back RNA synthesisenterovirus A71favipiravirpolioviruspyrazine-carboxamide analoguerecombinationRNA-dependent RNA polymeraseT-1106template switching

Identifiers

PMID34687604
PMCPMC8628313

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.